Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Stock Rated “Moderate Buy” by Sell-Side Brokerages

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) has earned an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $197.50.

Several brokerages have issued reports on SLGL. HC Wainwright restated a “buy” rating on shares of Sol-Gel Technologies in a research note on Tuesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Sol-Gel Technologies in a report on Tuesday, September 1st. Finally, Mizuho initiated coverage on Sol-Gel Technologies in a research report on Wednesday, June 24th. They set an “outperform” rating and a $285.00 price target on the stock.

Insider Buying and Selling at Sol-Gel Technologies

In other Sol-Gel Technologies news, major shareholder Opaleye Management Inc. acquired 1,493 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were purchased at an average price of $65.94 per share, for a total transaction of $98,448.42. Following the completion of the purchase, the insider directly owned 540,000 shares in the company, valued at $35,607,600. The trade was a 0.28% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Over the last ninety days, insiders have bought 53,659 shares of company stock worth $3,701,674. 66.51% of the stock is owned by corporate insiders.

Institutional Trading of Sol-Gel Technologies

An institutional investor recently bought a new stake in Sol-Gel Technologies stock. Navellier & Associates Inc. purchased a new position in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,785 shares of the company’s stock, valued at approximately $429,000. Navellier & Associates Inc. owned about 0.21% of Sol-Gel Technologies as of its most recent filing with the Securities & Exchange Commission. 26.18% of the stock is currently owned by hedge funds and other institutional investors.

Sol-Gel Technologies Trading Down 4.9%

SLGL stock opened at $71.94 on Thursday. The firm has a 50 day simple moving average of $73.58 and a 200-day simple moving average of $74.35. The company has a market capitalization of $202.15 million, a P/E ratio of -12.76 and a beta of 1.14. Sol-Gel Technologies has a twelve month low of $28.81 and a twelve month high of $97.97.

Sol-Gel Technologies (NASDAQ:SLGL) last posted its quarterly earnings data on Friday, August 21st. The company reported ($1.13) EPS for the quarter, beating analysts’ consensus estimates of ($2.36) by $1.23. The firm had revenue of $0.59 million for the quarter, compared to the consensus estimate of $0.07 million. Sol-Gel Technologies had a negative net margin of 910.14% and a negative return on equity of 44.05%. On average, research analysts predict that Sol-Gel Technologies will post -4.95 EPS for the current year.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is an Israeli specialty pharmaceutical company focused on developing and commercializing topical dermatological treatments. The company uses proprietary silica-based microsponge technology designed to encapsulate and gradually release active pharmaceutical ingredients in the skin.

Its marketed products include TWYNEO, a topical cream combining tretinoin and benzoyl peroxide for the treatment of acne vulgaris, and EPSOLAY, a topical benzoyl peroxide cream for the treatment of inflammatory lesions associated with rosacea.